Our mission: allow scientists in research and pharmaceutical drug development to excel with the highest quality genomic sequencing data and proteomic data at rapid turnaround times, with the best possible support, all at industry leading pricing.
BGI Genomics is the world’s leading provider of genomic sequencing services and proteomic services, now serving customers in more than 100 countries. We provide academic institutions, pharmaceutical companies, health care providers and other organizations with integrated genomic sequencing and proteomic services and solutions across a broad range of applications spanning:
• Basic research covering human, plant, animal and microbial species
• Clinical research in human health
• Drug discovery and development
• Agriculture and Biodiversity preservation and sustainability
We have almost 20 years of genomics experience helping our customers achieve their research goals by delivering rapid, high quality results using a broad array of cost-effective, cutting-edge technologies, including our own innovative DNBSEQ™ sequencing technology. Contact us to find out how we can assist with your project, we’re confident we can help.
Active in 100+ countries
Sequenced 1% of the original Human Genome Project
150,000+ human whole genomes sequenced to date